<![CDATA[What's new in feline care: A parasiticide approval and 3 new nutrition products]]>

Drugs & Regulation

FDA Approves Quarterly Feline Parasiticide Felpreva as Purina Adds Feline Nutrition Line

The FDA approved Felpreva, a topical feline parasiticide applied 4 times a year, while Purina launches a stress-focused urinary diet and 2 liquid feline supplements.

Photo: mirkosajkov / pixabay

The FDA has approved Felpreva, a broad-spectrum topical parasiticide for cats that requires application only 4 times a year, manufacturer Vetoquinol announced on November 16, 2026. The approval gives U.S. feline practitioners a quarterly alternative in a parasite-control segment long dominated by monthly dosing schedules.

Felpreva is prescription-only and approved for use in cats exclusively. Vetoquinol Chairman and CEO Matthieu Frechin framed the U.S. launch as an access milestone: "We are excited to bring Felpreva to U.S. veterinarians and cat owners," he said in the company's news release.

What does the product contain?

The product is not a new molecule globally. The European Commission granted marketing authorization in 2021, and a European Union launch followed in 2022. Under that European authorization, Felpreva combines 3 active ingredients: tigolaner, emodepside, and praziquantel.

Tigolaner, the isoxazoline-class component, targets fleas, ticks, and mites. Emodepside and praziquantel round out the broad-spectrum claim.

What does one dose cover?

The European label defines the scope. A single dose covers tapeworms, gastrointestinal roundworms, lungworms, fleas, ticks, and mites for up to 3 months, according to the 2021 authorization. The European license also includes treatment of mild to moderate cases of notoedric mange and permits use as part of a treatment strategy for flea allergic dermatitis.

One gap remains for U.S. practitioners: Vetoquinol's announcement did not detail which parasites appear on the U.S. label. Veterinarians will need to read the approved labeling before extrapolating the European coverage claims, particularly for lungworm and notoedric mange indications, into domestic clinical use.

The four-times-yearly schedule is the practical selling point. Cats that resist monthly handling stand to benefit most, and the product's prescription-only status keeps dosing decisions inside the clinic rather than on the retail shelf.

What is new in feline nutrition?

The same month brought 3 feline product announcements from Purina Pro Plan Veterinary, released November 12: 1 therapeutic diet and 2 liquid supplements.

The diet, Pro Plan Veterinary Diets UR Urinary St/Ox + Calm Feline Formula, pairs urinary nutrition with support for calm behavior, aiming at cats with stress-related urinary conditions. According to the company, the formula dissolves struvite stones and reduces the risk of both struvite and calcium oxalate stone recurrence. It becomes available November 23.

The launch reflects how Purina sees the category evolving. Martha Cline, DVM, DACVIM, a veterinary nutritionist with Purina, said in the release that "today's solutions must account for more than just cats' clinical needs." Cline added that such solutions also have to work in pet owners' day-to-day lives.

For practices, the formula consolidates two interventions into one product: dissolution and recurrence prevention for struvite, plus calcium oxalate risk reduction, alongside a behavioral component aimed at the stress pathway that drives many feline lower urinary tract presentations.

How do the two supplements fit?

Both supplements are liquids and are available now, per the company's November 12 announcement.

  • Joint Care — formulated with omega-3 fatty acids to support joints, mobility, and comfort, plus L-leucine to help maintain muscle.
  • Hairball Care — contains functional cellulose, which Purina said helps eliminate hair from the digestive tract, minimizes hairball formation, and supports normal bowel function and stool quality. The company designed this supplement for cats that need hairball support while staying on a current diet.

The hairball positioning matters at the exam table. It offers an option for cats whose owners want hairball management without a diet change, which is often the sticking point in multi-cat households or with cats on therapeutic nutrition for other conditions.

What happens next?

Felpreva's U.S. rollout will test whether a quarterly, prescription-only parasiticide can shift feline compliance patterns built around monthly topicals, while the November 23 availability date for the UR St/Ox + Calm formula gives clinics a concrete window to update their feline urinary and parasite-control protocols.

Source: dvm360.com

Share this article:

Grace Kim

Show full bio

Staff writer covering regulation, policy and their impact on Small- and large-animal clinical practice at The Vet Scope.

More from Grace Kim →